HYQVIA
Live / Registered — Registered and renewed (as of 16 May 2025)
What this means for you
Registered since 13 Jan 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Jan 2025).
Record
- Serial number
- 85239796
- Registration number
- 4669391
- Mark type
- Stylized text
- Filed
- 11 Feb 2011
- Published for opposition
- 28 Oct 2014
- Registered
- 13 Jan 2015
- Next maintenance due
- 13 Jan 2025
- Attorney of record
- KARL M ZIELAZNICKI
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- BAXALTA INCORPORATED, BANNOCKBURN, IL, US
- Baxter International Inc., Deerfield, IL, US
- Baxter International Inc., Deerfield, IL, US
- Baxter International Inc., Deerfield, IL, US
Prosecution history
- 24 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 May 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 May 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 16 May 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 16 May 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Dec 2024 — TEAS SECTION 8 & 9 RECEIVED
- 13 Jan 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 27 Mar 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 27 Mar 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 27 Mar 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Jan 2021 — TEAS SECTION 8 RECEIVED
- 30 Jul 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jul 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED